Taniue et al. found that lncRNA UPAT and UHRF1 may be promising molecular targets for the therapy of colon cancer by regulating protein ubiquitination and degradation and thereby play a critical role in the survival and tumorigenicity of cancer cells [35]. This evidence concerns the gene UHRF1 and malignant colon neoplasm.